Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects
Status:
Recruiting
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Safety, Efficacy and
Pharmacokinetics of DPI 386 Nasal Gel for the Prevention and Treatment of Nausea Associated
with Motion Sickness in Senior Subjects With Open-Label Follow-Up